Introduction
Focus on gender-related issues for women with epilepsy has increased in the more recent years. The emphasis however, has been on the childbearing years. Contraceptives and pregnancy issues for women with epilepsy has received its justified attention. Menopause is the only gender specific event that is ubiquitous for all women within a certain period. The population is aging, over 13% of the population is stipulated to be over 65 in year 2005. 1 After menopause, a woman in a developed country can expect to Seizure (2008) Summary Hormonal fluctuations in the menstrual cycle have been shown to have an impact on the epilepsy in women with catamenial epilepsy. The epilepsy frequency is higher in the elderly, and this part of the population is steadily increasing. It is therefore of interest whether the hormonal changes in the menopausal transition affects the epilepsy. The perimenopause is associated with hormonal fluctuations and may worsen the epilepsy in women with catamenial epilepsy. It has been suggested that seizures may improve after menopause, particularly in the women with catamenial epilepsy. There is still however, limited data on the effects of menopause on the epilepsy. Prospective studies imply a long time span, and research in this field is scarce. More research on the relationship between hormonal fluctuations and seizures may enable us to predict the effect on the epilepsy. Special awareness should be given to a woman with epilepsy in the menopausal transition. # 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
live one-third of her life. The average rate for epilepsy in the entire population has remained more or less constant at about 45/100,000 while the incidence for epilepsies in the elderly has increased over the last decades to about 111/100,000.
2 Thus, the relationship between epilepsy and menopause may be important for a large group of patients.
Epilepsy can interfere with the time of menopause. Herzogs group 3 was the first to report an association between partal epilepsy and premature menopause. Harden et al. 4 found a relationship between the seizure frequency and age at menopause, and Klein et al. 5 have found an increased frequency of premature ovarian failure in women with epilepsy.
Menopause may also interfere with the epilepsy, and the aim of the present review is to summarize our knowledge of this effect.
Hormonal changes
The normal hormonal fluctuations before the menopausal transition and the effects known of hormones on seizures might also be of importance in the evaluation of the hormonal changes in the menopausal transition and its effect on the epilepsy. 6 The gonadal hormones estrogen and progesterone have been shown to affect seizure activity. Estrogen has been found to increase neuronal excitability 7 and progesterone 8 on the other hand to elevate seizure threshold. The fluctuations of these hormones through the menstrual cycle have been found to explain catamenial epilepsy; an exacerbation of seizures perimenstrually, periovulatory and in inadequate luteal phase cycles. 9 The perimenopause is defined as a period of menstrual irregularity with increasing episodes of amenorrhea culminating in natural menopause, which is defined as no menses for 12 consecutive months with no obvious cause. 10 The time from reproductive years to menopause usually occurs over approximately 4 years. 11 Progressive decreases in inhibin A and B result in an early increase in follicle stimulating hormone which initially maintains folliculogenesis and estradiol secretion. 12 Over time, regular ovulatory cycles give way to inconsistent folliculogenesis and ovulation. FSH and LH decrease after menopause while GnRH increases. This suggests adaptability of the aging brain and alteration of the pituitary responsiveness to GnRH.
Impact on epilepsy
Studies on the impact of menopause on onset of epilepsy or frequency of epilepsy have been scarce.
Prospective studies are difficult due to a wide range of age for menopause; most women experience menopause between 40 and 58 years of age.
In a study from Poland, 13 Rosciszewska was the first to report an increased risk for seizure onset or epilepsy worsening during perimenopause. The results indicated that seizure frequency was more likely to improve during menopause if there was a catamenial relationship, if seizures began later in life, and if seizures were well controlled. A questionnaire study of women with epilepsy currently in menopause and perimenopause 6 by Harden et al., showed that an approximately similar number of women had no change, increase or decrease in their seizure frequency. For the women with a catamenial seizure pattern however, an association was found with seizure increase in perimenopause and decrease after menopause.
In another study Abbasi et al. 14 used a structured interview to analyse the characteristics and temporal relation of the seizures to menopause and compared the frequency and severity of the seizures with those in a similar group of premenopausal women. Seventy-four percent of the women reported that either their epilepsy changed or first began during menopause, 20% of the menopausal women noted that their seizures first began during or after menopause. Among the women with established epilepsy, 41% reported worsening of their seizures with menopause, 27% noted improvement, and 33% described no changes. In a brief communication by McAuley et al. 15 conducting a telephone interview of postmenopausal women no significant differences were found.
As outlined, although it has been thought that there is a trend towards fewer seizures after established menopause, one cannot from the human studies predict the different effects on seizures caused by the perimenopause/menopause. What can explain these different effects?
Animal studies that might elucidate what impact menopause could have on seizures are those of ovariectomized animals. Tominaga et al. 16 found that ovariectomy in rats elevated the susceptibility to cyclosporine A-induced convulsions by affecting the inhibitory action of cyclosporine A on GABA neural activity in the hippocampus. Scharfman et al. 17 have recently done a study showing ovariectomized rats with a more rapid progression to status epilepticus and also how age was of importance.
In the ovariectomized animals however, the hormonal changes in the animals are abrupt in contrast to the gradual hormonal changes found in the menopausal transition. It might be the concerted lack of estradiol and progesterone that facilitate the seizure susceptibility. Both estradiol and progesterone affect GABAergic function. [17] [18] [19] The simultaneous decrease of estrogen and progesterone may thereby lead to a decrease in GABAergic inhibition, facilitating seizures.
Recently published results by Lavaque et al. 20 suggest age-related focal production of sex hormones especially prominent in the hippocampus and cerebral cortex. The expression of the steroidogenic acute regulatory protein was found to increase particularly in these areas. The hippocampus and cerebral cortex are areas associated with seizure initiation and propagation. It is therefore discussed how pathological disturbances in the local estrogen production after menopause may contribute to an increase in seizures in some women. 21 The perimenopausal period is associated with more extreme fluctuations of estradiol and progesterone than what is found during the menstrual cycles of the productive years. 22 The decreases in estradiol occur relatively late in the transition to menopause compared with decreases in inhibin, which is an early marker of ovarian aging, and the estradiol levels do not reach their lowest concentrations until the year following the last menstrual period. 22, 23 The elevation of the estrogen to progesterone ratio seen in the perimenopause may lead to exacerbation of seizures particularly in those with a catamenial pattern.
In a recently published review, Scharfman and Maclusky 24 discuss the importance of the circulating estrogens. Estrone is the primary estrogen after menopause. Its main source is subcutaneous fat. This might be of importance for women with epilepsy that are overweight. Little is known on the influence of estrone on epilepsy. An altered ratio of estradiol/ estriol/estrone might be of importance, this has not however, been investigated. Most likely, however, the hormonal changes in menopause may not affect the different types of epilepsy in the same way.
Conclusion
The marked hormonal changes in the menopausal transition seem to have an effect on seizure susceptibility. Women with catamenial epilepsy might experience an increase in seizure frequency in perimenopause and decrease after menopause. Other patients may experience either increase or decrease in seizure activity. There is limited knowledge of the impact of menopause on the different forms of epilepsy. However, the probability for a change in seizure frequency in the menopausal transition is high and medical adjustments may be necessary. The amounts of women with epilepsy in higher age groups are steadily increasing, and they deserve an increased awareness and attention around the time of perimenopause and menopause.
